FDA Pulls Emergency Plug on Pfizer, Moderna, and Novavax COVID Shots
Published Date: 10/2/2025
Notice
Summary
The FDA is ending the emergency use permissions for Pfizer, Moderna, and Novavax COVID-19 vaccines. This means these vaccines are no longer authorized under emergency rules, signaling a shift as the pandemic changes. People and healthcare providers should note this update, but it doesn’t mean the vaccines are unsafe or unavailable through regular approvals.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 0 costs, 1 mixed.
EUA Revoked for Three COVID-19 Vaccines
The FDA revoked the Emergency Use Authorizations (EUAs) for Pfizer‑BioNTech COVID‑19 Vaccine, Moderna COVID‑19 Vaccine, and Novavax COVID‑19 Vaccine, Adjuvanted, so these products are no longer authorized under emergency rules. The notice says this change does not mean the vaccines are unsafe and that they may still be available through regular (non‑emergency) approval pathways.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in